From The Epoch Times November 10, 2020 | Isabel van Brugen U.S. drug regulators granted Eli Lilly’s COVID-19 antibody drug an emergency-use authorization on Monday, widening access to a therapy that has shown improvement in treating patients with mild to moderate cases of the CCP (Chinese Communist Party) virus. The Food and Drug Administration (FDA) cleared…
Contact NatsWritings
